Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Phase 3    crawled date : 2021 - 06 - 03    save search

New Phase 3 Data at WCPGHAN Show Long-Term Safety, Tolerability, and Treatment Benefits of Bylvay™ (odevixibat) in PFIC
Published: 2021-06-03 (Crawled : 21:00) - globenewswire.com
ALBO | $44.15 -0.23% 0.39% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 2.16% C: -1.61%

treatment phase 3
Valneva Completes Phase 3 Trial Recruitment for its Inactivated COVID-19 Vaccine Candidate
Published: 2021-06-03 (Crawled : 18:00) - globenewswire.com
DVAX | $11.35 -0.7% -0.7% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: -1.07% H: 3.6% C: 2.76%

covid vaccine phase 3 trial covid-19
Avadel to Present New Efficacy and Safety Data from Pivotal Phase 3 REST-ON Trial of FT218 at SLEEP 2021
Published: 2021-06-03 (Crawled : 14:00) - globenewswire.com
AVDL | $17.4 -3.28% -3.39% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 1.38% H: 0.5% C: -2.1%

phase 3 ft218 trial
Actinium Announces Several Presentations from the Phase 3 SIERRA Study of Iomab-B at the SNMMI 2021 Virtual Annual Meeting
Published: 2021-06-03 (Crawled : 14:00) - biospace.com/
ATNM | $6.67 -8.0% 0.0% 420K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 5.43% C: 4.81%

presentation phase 3
Tonix Pharmaceuticals Presents Positive Results from Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
Published: 2021-06-03 (Crawled : 13:15) - globenewswire.com
TNXP | $0.1549 -2.82% -2.91% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 3.23% C: 0.0%

positive results positive results phase 3 fibromyalgia
United Therapeutics Announces First Patient Enrolled In Phase 3 TETON Study Of Tyvaso In Patients With Idiopathic Pulmonary Fibrosis
Published: 2021-06-03 (Crawled : 12:00) - biospace.com/
UTHR | $237.16 0.79% 0.78% 480K twitter stocktwits trandingview |
Health Technology
| | O: -0.04% H: 2.79% C: 2.13%

fibrosis phase 3 enroll
Gainers vs Losers
66% 34%

Top 10 Gainers
AGBA | $1.02 155.0% 60.78% 120M twitter stocktwits trandingview |
Finance

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | $0.92 84.0% 45.65% 900K twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

ZCMD | $2.44 78.1% 43.85% 330K twitter stocktwits trandingview |
Commercial Services

XPON | $3.1 60.62% 37.74% 16M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.